Fund research to the recipient in the amount of 1,927,669 on contract HR0011-16-2-0029.

Ended Cooperative Agreement Awarded Last action

Award ID
HR00111620029
Recipient
Awarding agency
Obligated
$63,273,730

Award facts

Assistance listing
12.910 Research and Technology Development
Completion date
Originally
Place of performance
Ellicott City, MD 21042, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment The purpose of this modification, as authorized by purchase requisition HR0011258937-001 is to issue exhibit B revision 8 research description document, exhibit… $0
Amendment The purpose of this MOD is to correct the LOA that previously funded the line. $0
Amendment The purpose of this MOD is to revise due dates, add new MS, extend the POP, and change the PM. $11,000,000
Amendment Make-IT program. The purpose of this modification is to: revise the milestone due dates, create new milestones, realign funding, and extend the performance… $0
Amendment The purpose of this modification is to (1) revise the due dates for milestones 27 through 36 and milestone 42 (2) replace exhibit B revision 4, research… $0
Amendment Covid 19 REA. The purpose of this modification is to add covid-19 work in support of the make IT program. This modification is to add $20,000,000 of within… $20,000,000
Amendment The purpose of this modification is to add covid-19 work in support of the make-IT program. $23,856,409
Amendment The purpose of this modification is to, 1 fully fund milestones 35-37 and 2 update exhibit C payable milestones with version P00009 dated march 31, 2020 $600,913
Amendment The purpose of this modification is to: fully fund milestones 27-34 update exhibit C payable milestones and change the agreements officer to shane lomelin. $1,096,864
Amendment The purpose of this modification is to add funding in the amount of 1,538,000 on contract HR0011-16-2-0029 P00007. $1,538,000
Amendment The purpose of this modification is to extend the POP and add funding in the amount of 1,377,000 on contract HR0011-16-2-0029 P00006. $1,377,000
Amendment The purpose of this modification is to add funding in the amount of 90,000 and extend the POP on contract HR0011-16-2-0029 P00005. $90,000
Amendment The purpose of this medication is to fully fund this agreement by adding 31,640 to contract HR0011-16-2-0029 P00004. $31,640
Amendment $1,349,989
Amendment The purpose of this modification is to incrementally fund in the amount of 246,558 on contract HR0011-16-2-0029 P00002. $246,558
Amendment The purpose of this modification is to incrementally fund line item 0004 in the amount of 158,688 on contract HR0011-16-2-0029 P00001. $158,688
Original award $1,927,669
Show all 17

Quick answers

Who received award HR00111620029?

HR00111620029 was awarded to On Demand Pharmaceuticals Inc. by Defense Advanced Research Projects Agency (Department of Defense) on July 1, 2016.

How much is award HR00111620029 worth?

$63,273,730 has been obligated on HR00111620029.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login